MICHELE YARMAN: Open Payments
NPI 1245225184 · MOUNT VERNON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 38 payments from 13 companies in 2025. Trend: 2023 $948 · 2024 $778 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $197 |
| Novo Nordisk Inc | 12 | $157 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Amgen Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VRAYLAR, Ozempic, QULIPTA, Wegovy, Symbravo, VOQUEZNA, UBRELVY, OTEZLA.
Industry payments across OH — which companies pay providers there.
